Sunesis Advisors, LLC - Q4 2018 holdings

$91.7 Million is the total value of Sunesis Advisors, LLC's 27 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 120.0% .

 Value Shares↓ Weighting
VTI BuyVANGUARD INDEX FDStotal stk mkt$33,963,000
-11.5%
266,102
+3.8%
37.05%
-4.3%
AGG BuyISHARES TRcore us aggbd et$13,223,000
+8.6%
124,167
+7.6%
14.43%
+17.4%
VXUS BuyVANGUARD STAR FDvg tl intl stk f$5,532,000
-11.1%
117,149
+1.6%
6.04%
-3.9%
VEA BuyVANGUARD TAX MANAGED INTL FDftse dev mkt etf$3,662,000
+8.8%
98,694
+26.8%
4.00%
+17.6%
VWO BuyVANGUARD INTL EQUITY INDEX Fftse emr mkt etf$1,887,000
-5.1%
49,520
+2.1%
2.06%
+2.6%
IUSB NewISHARES TRcore total usd$709,00014,403
+100.0%
0.77%
VTV NewVANGUARD INDEX FDSvalue etf$525,0005,357
+100.0%
0.57%
BND NewVANGUARD BD INDEX FD INCtotal bnd mrkt$354,0004,475
+100.0%
0.39%
SPY NewSPDR S&P 500 ETF TRtr unit$321,0001,286
+100.0%
0.35%
BAC NewBANK AMER CORP$268,00010,873
+100.0%
0.29%
FFTY NewINNOVATOR ETFS TRibd 50 etf$239,0008,666
+100.0%
0.26%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-01-25
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VANGUARD INDEX FDS21Q3 202347.2%
ISHARES TR21Q3 202314.4%
VANGUARD STAR FDS21Q3 20237.3%
ISHARES TR21Q3 20235.8%
DECIPHERA PHARMACEUTICALS IN21Q3 20235.5%
VANGUARD SCOTTSDALE FDS21Q3 20233.6%
PIMCO ETF TR21Q3 20233.2%
ISHARES TR21Q3 20232.3%
VANGUARD INTL EQUITY INDEX F21Q3 20232.3%
VANGUARD INTL EQUITY INDEX F21Q3 20232.3%

View Sunesis Advisors, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-04-29
13F-HR2024-01-19
13F-HR2023-10-20
13F-HR2023-04-27
13F-HR2023-02-02
13F-HR2022-11-02
13F-HR2022-07-27
13F-HR2022-05-05
13F-HR2022-02-11
13F-HR2021-10-27

View Sunesis Advisors, LLC's complete filings history.

Compare quarters

Export Sunesis Advisors, LLC's holdings